These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

306 related articles for article (PubMed ID: 29875132)

  • 1. NF-κB activation in astrocytes drives a stage-specific beneficial neuroimmunological response in ALS.
    Ouali Alami N; Schurr C; Olde Heuvel F; Tang L; Li Q; Tasdogan A; Kimbara A; Nettekoven M; Ottaviani G; Raposo C; Röver S; Rogers-Evans M; Rothenhäusler B; Ullmer C; Fingerle J; Grether U; Knuesel I; Boeckers TM; Ludolph A; Wirth T; Roselli F; Baumann B
    EMBO J; 2018 Aug; 37(16):. PubMed ID: 29875132
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The BCL-2 family protein Bid is critical for pro-inflammatory signaling in astrocytes.
    König HG; Coughlan KS; Kinsella S; Breen BA; Prehn JH
    Neurobiol Dis; 2014 Oct; 70():99-107. PubMed ID: 24956542
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Microglia induce motor neuron death via the classical NF-κB pathway in amyotrophic lateral sclerosis.
    Frakes AE; Ferraiuolo L; Haidet-Phillips AM; Schmelzer L; Braun L; Miranda CJ; Ladner KJ; Bevan AK; Foust KD; Godbout JP; Popovich PG; Guttridge DC; Kaspar BK
    Neuron; 2014 Mar; 81(5):1009-1023. PubMed ID: 24607225
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immune reactivity in a mouse model of familial ALS correlates with disease progression.
    Alexianu ME; Kozovska M; Appel SH
    Neurology; 2001 Oct; 57(7):1282-9. PubMed ID: 11591849
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tweak regulates astrogliosis, microgliosis and skeletal muscle atrophy in a mouse model of amyotrophic lateral sclerosis.
    Bowerman M; Salsac C; Coque E; Eiselt É; Deschaumes RG; Brodovitch A; Burkly LC; Scamps F; Raoul C
    Hum Mol Genet; 2015 Jun; 24(12):3440-56. PubMed ID: 25765661
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Toll-Like Receptor-4 Inhibitor TAK-242 Attenuates Motor Dysfunction and Spinal Cord Pathology in an Amyotrophic Lateral Sclerosis Mouse Model.
    Fellner A; Barhum Y; Angel A; Perets N; Steiner I; Offen D; Lev N
    Int J Mol Sci; 2017 Aug; 18(8):. PubMed ID: 28763002
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Knocking down metabotropic glutamate receptor 1 improves survival and disease progression in the SOD1(G93A) mouse model of amyotrophic lateral sclerosis.
    Milanese M; Giribaldi F; Melone M; Bonifacino T; Musante I; Carminati E; Rossi PI; Vergani L; Voci A; Conti F; Puliti A; Bonanno G
    Neurobiol Dis; 2014 Apr; 64():48-59. PubMed ID: 24361555
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Innate immunity in amyotrophic lateral sclerosis.
    Moisse K; Strong MJ
    Biochim Biophys Acta; 2006; 1762(11-12):1083-93. PubMed ID: 16624536
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD44 expression in astrocytes and microglia is associated with ALS progression in a mouse model.
    Matsumoto T; Imagama S; Hirano K; Ohgomori T; Natori T; Kobayashi K; Muramoto A; Ishiguro N; Kadomatsu K
    Neurosci Lett; 2012 Jun; 520(1):115-20. PubMed ID: 22634473
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Downregulated Glia Interplay and Increased miRNA-155 as Promising Markers to Track ALS at an Early Stage.
    Cunha C; Santos C; Gomes C; Fernandes A; Correia AM; Sebastião AM; Vaz AR; Brites D
    Mol Neurobiol; 2018 May; 55(5):4207-4224. PubMed ID: 28612258
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IL-10 Controls Early Microglial Phenotypes and Disease Onset in ALS Caused by Misfolded Superoxide Dismutase 1.
    Gravel M; Béland LC; Soucy G; Abdelhamid E; Rahimian R; Gravel C; Kriz J
    J Neurosci; 2016 Jan; 36(3):1031-48. PubMed ID: 26791230
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In-vivo effects of knocking-down metabotropic glutamate receptor 5 in the SOD1
    Bonifacino T; Cattaneo L; Gallia E; Puliti A; Melone M; Provenzano F; Bossi S; Musante I; Usai C; Conti F; Bonanno G; Milanese M
    Neuropharmacology; 2017 Sep; 123():433-445. PubMed ID: 28645622
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuroprotective effects of the Sigma-1 receptor (S1R) agonist PRE-084, in a mouse model of motor neuron disease not linked to SOD1 mutation.
    Peviani M; Salvaneschi E; Bontempi L; Petese A; Manzo A; Rossi D; Salmona M; Collina S; Bigini P; Curti D
    Neurobiol Dis; 2014 Feb; 62():218-32. PubMed ID: 24141020
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Appearance of phagocytic microglia adjacent to motoneurons in spinal cord tissue from a presymptomatic transgenic rat model of amyotrophic lateral sclerosis.
    Sanagi T; Yuasa S; Nakamura Y; Suzuki E; Aoki M; Warita H; Itoyama Y; Uchino S; Kohsaka S; Ohsawa K
    J Neurosci Res; 2010 Sep; 88(12):2736-46. PubMed ID: 20648658
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The CB2 cannabinoid agonist AM-1241 prolongs survival in a transgenic mouse model of amyotrophic lateral sclerosis when initiated at symptom onset.
    Shoemaker JL; Seely KA; Reed RL; Crow JP; Prather PL
    J Neurochem; 2007 Apr; 101(1):87-98. PubMed ID: 17241118
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vivo imaging reveals rapid morphological reactions of astrocytes towards focal lesions in an ALS mouse model.
    Dibaj P; Steffens H; Zschüntzsch J; Kirchhoff F; Schomburg ED; Neusch C
    Neurosci Lett; 2011 Jun; 497(2):148-51. PubMed ID: 21539893
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of the PPARgamma activator pioglitazone on p38 MAP kinase and IkappaBalpha in the spinal cord of a transgenic mouse model of amyotrophic lateral sclerosis.
    Shibata N; Kawaguchi-Niida M; Yamamoto T; Toi S; Hirano A; Kobayashi M
    Neuropathology; 2008 Aug; 28(4):387-98. PubMed ID: 18312546
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Actions of the antihistaminergic clemastine on presymptomatic SOD1-G93A mice ameliorate ALS disease progression.
    Apolloni S; Fabbrizio P; Amadio S; Volonté C
    J Neuroinflammation; 2016 Aug; 13(1):191. PubMed ID: 27549088
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatocyte growth factor (HGF) attenuates gliosis and motoneuronal degeneration in the brainstem motor nuclei of a transgenic mouse model of ALS.
    Kadoyama K; Funakoshi H; Ohya W; Nakamura T
    Neurosci Res; 2007 Dec; 59(4):446-56. PubMed ID: 17935811
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Muscle-derived but not centrally derived transgene GDNF is neuroprotective in G93A-SOD1 mouse model of ALS.
    Li W; Brakefield D; Pan Y; Hunter D; Myckatyn TM; Parsadanian A
    Exp Neurol; 2007 Feb; 203(2):457-71. PubMed ID: 17034790
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.